#142: Digital rehab in MS – what new technology can (and can't) do for you. An ECTRIMS 2025 Special

#142: Digital rehab in MS – what new technology can (and can't) do for you. An ECTRIMS 2025 Special

  • Maybe you already use your phone, a wearable, or one of the many MS-related apps to track your symptoms or support your daily routines. But when it comes to rehabilitation, the real question is: which digital tools actually help — and which ones are just noise?

In this ECTRIMS session, researchers from around the world explored how technology can enhance rehabilitation for people with MS. Their message was clear: digital tools can open new doors, but only when they are designed well, grounded in science, and truly support your everyday life.

You can read through the complete article here: https://ms-perspektive.de/EN/142-digital-rehab

In this episode, you'll hear about: 1. Alon Kalron – Israel

How digital technologies—from smartphones to sensor-based rehab tools—can extend what your rehab team can see and support between appointments.

2. Andrea Tacchino – Italy

Why digital outcome measurements matter, how sensors can capture real-life changes, and what it takes to turn raw data into meaningful digital biomarkers.

3. Gabriele Perachiotti – Italy

How high-intensity, task-oriented circuit training can improve balance, fatigue, and quality of life—even in people with severe mobility limitations—and how a simple home-based telerehab setup helps maintain progress.

4. Andrea Baroni – Italy

How machine-learning models can predict rehab outcomes and why your starting functional level is the strongest predictor of future improvement.

5. Diogo Haddad Santos – Brazil

Why "strange" visual symptoms in MS often reflect real, measurable eye-movement changes—and how portable eye-tracking may become a new digital biomarker.

6. Katrin Parmar – Switzerland

Which balance tests reflect high-tech lab measurements, and why static and dynamic balance need to be tested separately.

Topics we explore:
  • The promise and limits of MS apps & wearable sensors

  • Digital biomarkers for gait, balance, fatigue, and vision

  • Task-oriented training and telerehabilitation

  • Predicting rehab outcomes using machine learning

  • Eye-tracking and the hidden world of visual symptoms

  • Static vs. dynamic balance: why both matter

  • How to decide which digital tools are worth your time

What you'll take away:
  • Not every digital tool is useful — evidence and usability matter.

  • Sensors can capture changes that clinic visits miss.

  • Even with higher disability, meaningful rehab gains are possible.

  • Your starting function strongly shapes your rehab journey.

  • Subjective symptoms (like visual strain) deserve objective investigation.

  • The future of MS rehab is a blend of clinic + lab + digital.

---

See you soon and try to make the best out of your life,
Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(192)

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

https://ms-perspektive.de/en/190-unseen-faces-of-ms/Living with multiple sclerosis often means experiencing symptoms that others cannot see. Austrian artist Gabriela Romagna shares her journey to an M...

4 Nov 32min

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

How could new imaging in MS help us understand progression and develop better treatments? In this episode, I explore key insights from Daniel Reich's MSToronto2026 lecture and related research. Learn ...

28 Okt 15min

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

"Get rid of MS as soon as possible and make ourselves superfluous." — Jan van Amstel What can a stronger European voice achieve for people living with MS? In episode #188, EMSP President Jan van Amste...

21 Okt 31min

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

Aging in multiple sclerosis brings new questions about relapses, gradual progression and treatment choices. In episode 187, Dr. Yi Chao Foong, an MS neurologist and researcher in Tasmania, explains wh...

14 Okt 29min

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

Why can multiple sclerosis progress even when relapses are well controlled? In episode 186, I speak with Prof. Manuel Friese about the next challenge in MS research: protecting nerve cells from damage...

7 Okt 43min

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

An MS diagnosis can depend on where you live, whether you can reach a neurologist and how quickly you can get an MRI. In this episode, Nele speaks with neurologist and neuroimmunologist Dr. Enrique Go...

30 Sep 36min

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

Read the full blog post and interview here: https://ms-perspektive.de/en/184-klaus-schmierer/ How early should MS treatment start, how strongly should we treat, and is there ever a point when it becom...

23 Sep 41min

#183: Silent progression in MS. Can we really detect it early?

#183: Silent progression in MS. Can we really detect it early?

Can we detect gradual MS progression before it becomes obvious? In this episode, I look at what current research can — and cannot — tell us about subtle worsening without an obvious relapse. The key d...

16 Sep 34min

Populärt inom Utbildning

husmodern-med-amanda-schulman
historiepodden-se
det-skaver
rss-bara-en-till-om-beroende-medberoende
rosceremoni
nu-blir-det-historia
harrisons-dramatiska-historia
roda-vita-rosen
allt-du-velat-veta
rss-viktmedicinpodden
rss-dr-bjorklund
i-vantan-pa-katastrofen
not-fanny-anymore
sa-in-i-sjalen
sektledare
johannes-hansen-podcast
rss-basta-livet
rss-max-tant-med-max-villman
rss-traningsklubben
sektpodden